skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Show only
Refined by: subject: Anti-Obesity Agents - Therapeutic Use remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
Material Type:
Article 		Add to My Research

Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study

The Lancet (British edition), 2009-11, Vol.374 (9701), p.1606-1616 [Peer Reviewed Journal]

Elsevier Ltd ;2009 Elsevier Ltd ;2009 INIST-CNRS ;Copyright Elsevier Limited Nov 7-Nov 13, 2009 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(09)61375-1 ;PMID: 19853906 ;CODEN: LANCAO

Full text available

Citations Cited by
2
Tolerability of nausea and vomiting and associations with weight loss in a randomized trial of liraglutide in obese, non-diabetic adults
Tolerability of nausea and vomiting and associations with weight loss in a randomized trial of liraglutide in obese, non-diabetic adults
Material Type:
Article 		Add to My Research

Tolerability of nausea and vomiting and associations with weight loss in a randomized trial of liraglutide in obese, non-diabetic adults

International Journal of Obesity, 2014-05, Vol.38 (5), p.689-697 [Peer Reviewed Journal]

2015 INIST-CNRS ;COPYRIGHT 2014 Nature Publishing Group ;COPYRIGHT 2014 Nature Publishing Group ;Copyright Nature Publishing Group May 2014 ;Copyright © 2014 Macmillan Publishers Limited 2014 Macmillan Publishers Limited ;ISSN: 0307-0565 ;ISSN: 1476-5497 ;EISSN: 1476-5497 ;DOI: 10.1038/ijo.2013.149 ;PMID: 23942319 ;CODEN: IJOBDP

Full text available

Citations Cited by
3
Prevalence, Pathophysiology, Health Consequences and Treatment Options of Obesity in the Elderly: A Guideline
Prevalence, Pathophysiology, Health Consequences and Treatment Options of Obesity in the Elderly: A Guideline
Material Type:
Article 		Add to My Research

Prevalence, Pathophysiology, Health Consequences and Treatment Options of Obesity in the Elderly: A Guideline

Obesity facts, 2012, Vol.5 (3), p.460-483 [Peer Reviewed Journal]

2012 S. Karger GmbH, Freiburg ;ISSN: 1662-4025 ;EISSN: 1662-4033 ;DOI: 10.1159/000341193 ;PMID: 22797374

Full text available

Citations Cited by
4
Feasibility and indicative results from a 12-month low-energy liquid diet treatment and maintenance programme for severe obesity
Feasibility and indicative results from a 12-month low-energy liquid diet treatment and maintenance programme for severe obesity
Material Type:
Article 		Add to My Research

Feasibility and indicative results from a 12-month low-energy liquid diet treatment and maintenance programme for severe obesity

British journal of general practice, 2013-02, Vol.63 (607), p.e115-e124 [Peer Reviewed Journal]

British Journal of General Practice 2013 2013 ;ISSN: 0960-1643 ;EISSN: 1478-5242 ;DOI: 10.3399/bjgp13X663073 ;PMID: 23561690

Full text available

Citations Cited by
5
ABC of obesity: Management: Part II—Drugs
ABC of obesity: Management: Part II—Drugs
Material Type:
Article 		Add to My Research

ABC of obesity: Management: Part II—Drugs

BMJ (Online), 2006-10, Vol.333 (7572), p.794-797 [Peer Reviewed Journal]

2006 BMJ Publishing Group Ltd ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.333.7572.794 ;PMID: 17038738

Full text available

Citations Cited by
6
Efficacy and Safety of CP-945,598, a Selective Cannabinoid CB1 Receptor Antagonist, on Weight Loss and Maintenance
Efficacy and Safety of CP-945,598, a Selective Cannabinoid CB1 Receptor Antagonist, on Weight Loss and Maintenance
Material Type:
Article 		Add to My Research

Efficacy and Safety of CP-945,598, a Selective Cannabinoid CB1 Receptor Antagonist, on Weight Loss and Maintenance

Obesity (Silver Spring, Md.), 2011-07, Vol.19 (7), p.1404-1414 [Peer Reviewed Journal]

2011 North American Association for the Study of Obesity (NAASO) ;Copyright Nature Publishing Group Jul 2011 ;ISSN: 1930-7381 ;EISSN: 1930-739X ;DOI: 10.1038/oby.2010.352 ;PMID: 21293451

Full text available

Citations Cited by
7
Prediction of response to sibutramine therapy in obese non-diabetic and diabetic patients
Prediction of response to sibutramine therapy in obese non-diabetic and diabetic patients
Material Type:
Article 		Add to My Research

Prediction of response to sibutramine therapy in obese non-diabetic and diabetic patients

Diabetes, obesity & metabolism, 2006-03, Vol.8 (2), p.206-213

ISSN: 1462-8902 ;EISSN: 1463-1326 ;DOI: 10.1111/j.1463-1326.2005.00481.x ;PMID: 16448525

Full text available

Citations Cited by
8
Leisure-time activity is an important determinant of long-term weight maintenance after weight loss in the Sibutramine Trial on Obesity Reduction and Maintenance (STORM trial)
Leisure-time activity is an important determinant of long-term weight maintenance after weight loss in the Sibutramine Trial on Obesity Reduction and Maintenance (STORM trial)
Material Type:
Article 		Add to My Research

Leisure-time activity is an important determinant of long-term weight maintenance after weight loss in the Sibutramine Trial on Obesity Reduction and Maintenance (STORM trial)

The American journal of clinical nutrition, 2003-08, Vol.78 (2), p.209-214 [Peer Reviewed Journal]

2004 INIST-CNRS ;Copyright American Society for Clinical Nutrition, Inc. Aug 2003 ;ISSN: 0002-9165 ;EISSN: 1938-3207 ;DOI: 10.1093/ajcn/78.2.209 ;PMID: 12885699 ;CODEN: AJCNAC

Full text available

Citations Cited by
9
new evidence-based model for weight management in primary care: the Counterweight Programme
new evidence-based model for weight management in primary care: the Counterweight Programme
Material Type:
Article 		Add to My Research

new evidence-based model for weight management in primary care: the Counterweight Programme

Journal of human nutrition and dietetics, 2004-06, Vol.17 (3), p.191-208 [Peer Reviewed Journal]

2004 INIST-CNRS ;Copyright Blackwell Scientific Publications Ltd. Jun 2004 ;ISSN: 0952-3871 ;EISSN: 1365-277X ;DOI: 10.1111/j.1365-277X.2004.00517.x ;PMID: 15139891

Full text available

Citations Cited by
10
Emerging pharmacotherapy for treating obesity and associated cardiometabolic risk
Emerging pharmacotherapy for treating obesity and associated cardiometabolic risk
Material Type:
Article 		Add to My Research

Emerging pharmacotherapy for treating obesity and associated cardiometabolic risk

Asia Pacific journal of clinical nutrition, 2006-09, Vol.15 Suppl, p.55 [Peer Reviewed Journal]

ISSN: 0964-7058 ;EISSN: 1440-6047 ;PMID: 16928662

Full text available

Citations Cited by
11
Current approaches to obesity management in UK primary care: the counterweight programme
Current approaches to obesity management in UK primary care: the counterweight programme
Material Type:
Article 		Add to My Research

Current approaches to obesity management in UK primary care: the counterweight programme

Journal of human nutrition and dietetics, 2004-06, Vol.17 (3), p.183-190 [Peer Reviewed Journal]

2004 INIST-CNRS ;Copyright Blackwell Scientific Publications Ltd. Jun 2004 ;ISSN: 0952-3871 ;EISSN: 1365-277X ;DOI: 10.1111/j.1365-277X.2004.00528.x ;PMID: 15139890

Full text available

Citations Cited by

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (10)
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait